Overview
Under Development, FDA Approval Required.
Available On-Demand bio-medicine targeting tumor-associated antigens.
Will work for many breast cancer patients.
Delivered through intranodal injection
Engineered with next-generation sequencing and artificial intelligence.
Status
Pre-Clinical Feasibility
Gene Sequencing Clinical Study
Phase I Clinical Study